11/20
09:08 am
rprx
The Leukemia & Lymphoma Society (LLS) Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment [Yahoo! Finance]
Low
Report
The Leukemia & Lymphoma Society (LLS) Data at ASH Provides Glimpse into the Future of Blood Cancer Treatment [Yahoo! Finance]
11/14
04:37 pm
rprx
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare [Yahoo! Finance]
Low
Report
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare [Yahoo! Finance]
11/14
04:30 pm
rprx
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
Low
Report
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
11/13
07:25 am
rprx
Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues [Yahoo! Finance]
Low
Report
Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues [Yahoo! Finance]
11/8
09:09 am
rprx
Geron Secures $250M Funding and Strong Q3 Sales [Yahoo! Finance]
Medium
Report
Geron Secures $250M Funding and Strong Q3 Sales [Yahoo! Finance]
11/7
07:17 am
rprx
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million [Yahoo! Finance]
Low
Report
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million [Yahoo! Finance]
11/7
07:10 am
rprx
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
Low
Report
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
11/7
02:31 am
rprx
Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions [Yahoo! Finance]
Low
Report
Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions [Yahoo! Finance]
11/7
12:29 am
rprx
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight [Yahoo! Finance]
Low
Report
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight [Yahoo! Finance]
11/6
06:28 pm
rprx
Compared to Estimates, Royalty Pharma (RPRX) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Royalty Pharma (RPRX) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
11/6
10:15 am
rprx
Royalty Pharma (RPRX) Q3 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Medium
Report
Royalty Pharma (RPRX) Q3 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
11/6
07:20 am
rprx
Royalty Pharma Reports Third Quarter 2024 Results [Yahoo! Finance]
Medium
Report
Royalty Pharma Reports Third Quarter 2024 Results [Yahoo! Finance]
11/6
07:15 am
rprx
Royalty Pharma Reports Third Quarter 2024 Results
Medium
Report
Royalty Pharma Reports Third Quarter 2024 Results
11/5
02:15 am
rprx
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/4
04:15 pm
rprx
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
Low
Report
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
11/1
12:54 pm
rprx
AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down [Yahoo! Finance]
Low
Report
AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down [Yahoo! Finance]
11/1
10:55 am
rprx
Unveiling Royalty Pharma (RPRX) Q3 Outlook: Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Unveiling Royalty Pharma (RPRX) Q3 Outlook: Wall Street Estimates for Key Metrics [Yahoo! Finance]
10/28
11:10 pm
rprx
Royalty Pharma plc (NASDAQ: RPRX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/25
02:43 pm
rprx
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at Citigroup Inc. from $60.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at Citigroup Inc. from $60.00 to $40.00. They now have a "buy" rating on the stock.
10/21
01:00 pm
rprx
Thermo Fisher's Oncomine gains FDA approval as brain tumor diagnostic [Yahoo! Finance]
Low
Report
Thermo Fisher's Oncomine gains FDA approval as brain tumor diagnostic [Yahoo! Finance]
10/21
10:40 am
rprx
Want Better Returns? Don't Ignore These 2 Finance Stocks Set to Beat Earnings [Yahoo! Finance]
Low
Report
Want Better Returns? Don't Ignore These 2 Finance Stocks Set to Beat Earnings [Yahoo! Finance]
10/16
04:15 pm
rprx
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
Low
Report
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
10/14
07:05 am
rprx
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21 [Yahoo! Finance]
Low
Report
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21 [Yahoo! Finance]
10/11
08:23 am
rprx
Royalty Pharma Declares Fourth Quarter 2024 Dividend [Yahoo! Finance]
Low
Report
Royalty Pharma Declares Fourth Quarter 2024 Dividend [Yahoo! Finance]
10/11
08:15 am
rprx
Royalty Pharma Declares Fourth Quarter 2024 Dividend
Low
Report
Royalty Pharma Declares Fourth Quarter 2024 Dividend